13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)

An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);

A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);

(h)

A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act;

A church plan that is excluded from the definition
of an investment company under Section 3(c)(14) of the Investment Company Act;

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

Deerfield
Mgmt, L.P. – 1,214,423 shares

Deerfield Mgmt III, L.P. – 889,230 shares

Deerfield Management Company, L.P. –
2,103,653 shares

Deerfield Special Situations Fund, L.P. – 514,423 shares

Deerfield Partners, L.P. – 308,000 shares

Deerfield International Master Fund, L.P. – 392,000 shares

Deerfield Private Design Fund III, L.P. – 889,230 shares

James E. Flynn – 2,103,653 shares

Deerfield
Mgmt, L.P. – 4.38%

Deerfield Mgmt III, L.P. – 3.21%

Deerfield Management Company, L.P. – 7.59%

Deerfield Special
Situations Fund, L.P. – 1.86%

Deerfield Partners, L.P. – 1.11%

Deerfield International Master Fund, L.P. – 1.41%

Deerfield Private Design Fund III, L.P. – 3.21%

James E. Flynn – 7.59%

Deerfield Mgmt, L.P. – 1,214,423

Deerfield Mgmt III, L.P.
– 889,230

Deerfield Management Company, L.P. – 2,103,653

Deerfield Special Situations Fund, L.P. – 514,423

Deerfield Partners,
L.P. – 308,000

Deerfield International Master Fund, L.P. – 392,000

Deerfield Private Design Fund III, L.P. –
889,230

James E. Flynn – 2,103,653